Patent · US Active

Human cytomegalovirus vaccine

US10695419B2 · kind B2 · utility

66Cited by
45References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 19, 2019
Grant dateJun 30, 2020
Priority date—
Expiry dateApr 19, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.